Celldex Therapeutics, Inc. (CLDX) Financials
CLDX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 583.0 million | 55.8 million |
| Sept. 30, 2025 | 648.4 million | 50.1 million |
| June 30, 2025 | 692.4 million | 37.0 million |
| March 31, 2025 | 739.5 million | 36.5 million |
CLDX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -64.9 million | 8.9 million |
| Sept. 30, 2025 | -49.1 million | 8.8 million |
| June 30, 2025 | -44.7 million | 9.2 million |
| March 31, 2025 | -54.6 million | 9.3 million |
CLDX Net Income
No data available :(
CLDX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 518.6 million | - | 784000 |
| Sept. 30, 2025 | 583.2 million | - | 2.6 million |
| June 30, 2025 | 630.3 million | - | 3.0 million |
| March 31, 2025 | 673.3 million | - | 3.4 million |
CLDX Shares Outstanding
CLDX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 993000 | 75.4 million | 11.9 million | - |
| Sept. 30, 2025 | 440000 | 62.9 million | 10.7 million | - |
| June 30, 2025 | 728000 | 54.2 million | 10.4 million | - |
| March 31, 2025 | 265000 | 52.6 million | 10.8 million | - |
CLDX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 75000 | - |
| Sept. 30, 2025 | - | 62.9 million |
| June 30, 2025 | 730000 | - |
| March 31, 2025 | 695000 | - |
CLDX Revenue by Segment
Graph available only for paid members. Upgrade to see it.
CLDX
Price: $32.12
52 week price:
Earnings Per Share: -3.90 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 345800
Ebitda: -30.7 millionMarket Capitalization: 2.0 billion